Castle Creek Biosciences

Castle Creek Biosciences

Castle Creek Biosciences

Castle Creek Biosciences autologous cell and gene therapies target the underlying causes of diseases affecting the skin and connective tissue.
Type
B2c
Founded
2015
Raised
$75M
Follow us
Alexa global traffic share
Latest funding
$20,000,000
Debt financing - 2020
Horizon Technology Finance
Team Size
1–10
Employees
$55,000,000 Venture capital
FinSMEs

Castle Creek Biosciences Raises $75M in Funding